As you start a vivitrol medication management plan, you are taking a structured approach to support lasting recovery. This long-acting injectable treatment delivers naltrexone once a month to help block the effects of alcohol and opioids, reduce cravings, and reinforce your commitment to sobriety. Combining medication with counseling and ongoing monitoring creates a solid foundation for relapse prevention and sustained progress.
In this guide, you will learn how to understand Vivitrol’s basics, create key plan components, schedule injections reliably, secure insurance coverage and savings, track your treatment outcomes, and compare Vivitrol with other injectable options such as Sublocade. By following these steps, you can optimize your regimen and stay on course toward your recovery goals.
Understanding vivitrol basics
What vivitrol is
Vivitrol is an extended-release, injectable form of naltrexone approved by the FDA for preventing relapse in alcohol use disorder (approved in 2006) and opioid dependence (approved in 2010) [1]. Unlike opioid agonists, naltrexone does not activate opioid receptors, so it carries no risk of abuse, withdrawal upon discontinuation, or euphoria. Each intramuscular injection provides a full month of receptor blockade.
How it works
Vivitrol acts as an opioid antagonist, binding to opioid receptor sites in the brain so that alcohol or opioids cannot produce their usual rewarding effects. By blocking endorphin activity, it helps you stay motivated in treatment and reduces the risk of relapse.
- In alcohol use disorder, people using Vivitrol alongside counseling experienced a 25 percent greater reduction in heavy drinking days after treatment graduation [2].
- For opioid dependence, Vivitrol users were 17 times less likely to relapse and achieved 90 percent opioid-free weeks compared to those without it [2].
Creating your plan essentials
Medical supervision and monitoring
Before your first injection, you must undergo a full medical assessment to confirm that you have detoxed completely and maintained abstinence for at least 7–10 days to avoid precipitated withdrawal [2]. Your provider will:
- Review your medical history and current medications
- Order liver function tests and other labs as needed
- Inspect the injection site for any contraindications
Ongoing monitoring during each visit helps detect potential side effects—such as injection site reactions, liver enzyme elevations, or rare overdose risk if opioids are used concurrently [3]. Regular check-ins ensure your safety and support.
Counseling and support
Medication alone is rarely sufficient. Vivitrol must be used with other recovery programs, such as individual therapy, group counseling, or peer support groups, to maximize effectiveness [3]. Your plan should include:
- Cognitive behavioral therapy to address underlying thought patterns
- Relapse prevention sessions focusing on coping strategies
- Peer support or 12-step meetings to build community
By integrating your invivo treatment with counseling, you reinforce new habits and address triggers before they lead to setbacks. Many clients find value in local programs like our vivitrol and relapse prevention services.
Scheduling your injections
Monthly injection timeline
A consistent injection schedule is crucial. Most programs administer Vivitrol every 28–30 days to maintain steady receptor coverage. Your timeline may look like:
- Day 1 – Initiate injection after 7–10 days of confirmed abstinence
- Weeks 2–4 – Attend weekly or biweekly counseling sessions
- Day 28–30 – Return for next injection and medical check-in
Using reminders—phone apps, calendar alerts, or provider outreach—helps you stay on track. If you miss an appointment, contact your clinic promptly to minimize gaps in treatment coverage.
Telehealth follow up
When travel or work schedules create barriers, telehealth can bridge the gap for medical reviews and counseling check-ins. With telehealth, you can:
- Complete intake assessments remotely
- Review side effects and lab results with a clinician
- Attend virtual counseling sessions
Our vivitrol treatment with telehealth follow up option ensures you maintain continuity of care without sacrificing convenience.
Securing coverage and savings
Co pay savings details
The Vivitrol Co-pay Savings Program makes treatment affordable:
- 9 out of 10 eligible patients pay less than $5 out of pocket
- 99 percent of Medicaid recipients pay $4 or less
- Commercially insured or uninsured patients may pay $0 per injection, with up to $6,000 in annual savings [3]
Insurance verification steps
To confirm your benefits:
- Contact your insurer or use your provider’s benefits verification service
- Provide your plan details and NDC code for Vivitrol
- Ask about prior authorization requirements and step therapy criteria
- Coordinate with our billing team to expedite coverage
For assistance, see our insurance covered vivitrol injection guide or connect with an insurance verified injectable MAT program specialist.
Tracking your progress
Measuring treatment outcomes
Objective metrics help you and your care team evaluate effectiveness:
- Number of opioid-free or alcohol-free weeks
- Frequency of cravings on standardized scales
- Attendance at counseling and support sessions
- Liver function test results and other safety labs
Documenting these measures provides clarity on what’s working and where adjustments may be needed.
Plan adjustment strategies
Recovery is dynamic. Based on your progress, you might:
- Increase counseling frequency to address emerging triggers
- Adjust injection timing by a few days for scheduling flexibility
- Explore alternative or adjunctive medications
- Transition to a different injectable if clinically indicated
Discuss any concerns with your provider to refine your regimen and maintain momentum.
Integrating sublocade options
Comparing injectable treatments
If you are exploring long-acting injectable choices, consider how Vivitrol stacks up against Sublocade:
| Feature | Vivitrol | Sublocade |
|---|---|---|
| Active ingredient | Naltrexone (opioid antagonist) | Buprenorphine (partial opioid agonist) |
| Indication | Alcohol and opioid relapse prevention | Opioid use disorder maintenance |
| Dosing frequency | Once per month | Once per month |
| Controlled substance status | Not controlled | Schedule III controlled substance |
| Requirement before initiation | 7–10 days abstinence | No full detox required |
| Risk of diversion or misuse | None | Low but present |
Coordinating dual therapies
In some cases, clients may transition from one injectable to another or combine treatment strands. Coordination might involve:
- Consulting with both Vivitrol and Sublocade clinical teams
- Ensuring no overlap that could precipitate withdrawal or reduce efficacy
- Integrating counseling plans across medications to maintain consistency
Our resources on monthly sublocade treatment program and sublocade and counseling integration can help you navigate these options under professional guidance.
By understanding Vivitrol’s mechanism, structuring your management plan, securing reliable coverage, and tracking your recovery milestones, you set yourself up for sustained success. If you have questions or are ready to enroll in a medically supervised program, contact our team to arrange your first injection and counseling intake. Your path to lasting recovery is within reach.






